JP2008545715A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545715A5 JP2008545715A5 JP2008513812A JP2008513812A JP2008545715A5 JP 2008545715 A5 JP2008545715 A5 JP 2008545715A5 JP 2008513812 A JP2008513812 A JP 2008513812A JP 2008513812 A JP2008513812 A JP 2008513812A JP 2008545715 A5 JP2008545715 A5 JP 2008545715A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- betacellulin
- effective amount
- therapeutically effective
- situation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68570205P | 2005-05-27 | 2005-05-27 | |
| US70149005P | 2005-07-22 | 2005-07-22 | |
| US70206505P | 2005-07-22 | 2005-07-22 | |
| US70196405P | 2005-07-22 | 2005-07-22 | |
| US73379105P | 2005-11-07 | 2005-11-07 | |
| US73686605P | 2005-11-16 | 2005-11-16 | |
| US77816906P | 2006-02-27 | 2006-02-27 | |
| US80044306P | 2006-05-16 | 2006-05-16 | |
| US11/442,244 US20070054851A1 (en) | 2005-05-27 | 2006-05-30 | Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases |
| PCT/US2006/020797 WO2006128125A2 (en) | 2005-05-27 | 2006-05-30 | Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545715A JP2008545715A (ja) | 2008-12-18 |
| JP2008545715A5 true JP2008545715A5 (https=) | 2009-09-10 |
Family
ID=37452973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008513812A Pending JP2008545715A (ja) | 2005-05-27 | 2006-05-30 | 筋細胞へのグルコース取り込みを刺激する方法および組成物ならびに疾患を治療する方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070054851A1 (https=) |
| EP (1) | EP1890722A2 (https=) |
| JP (1) | JP2008545715A (https=) |
| AU (1) | AU2006249327A1 (https=) |
| CA (1) | CA2609728A1 (https=) |
| WO (1) | WO2006128125A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101605561A (zh) * | 2006-12-22 | 2009-12-16 | 诺韦利克斯治疗有限公司 | 通过至少一种表皮生长因子受体特异性抗体或其衍生物的糖尿病治疗 |
| US9173991B2 (en) * | 2007-07-02 | 2015-11-03 | Roche Diabetes Care, Inc. | Device for drug delivery |
| US20090156488A1 (en) * | 2007-09-12 | 2009-06-18 | Zensun (Shanghai) Science & Technology Limited | Use of neuregulin for organ preservation |
| US20090147006A1 (en) * | 2007-12-07 | 2009-06-11 | Roche Diagnostics Operations, Inc. | Method and system for event based data comparison |
| CN102139095A (zh) * | 2010-01-29 | 2011-08-03 | 上海泽生科技开发有限公司 | 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物 |
| BR112012029611A2 (pt) | 2010-05-21 | 2017-07-25 | Merrimack Pharmaceuticals Inc | proteína de fusão biespecífica, composição farmacêutica, método de tratamento de dano ao tecido em um indivíduo, método de promoção da regeração ou sobrevivência do tecido em um indivíduo e molécula de ácido nucleico |
| CN103118698A (zh) * | 2010-05-28 | 2013-05-22 | 意识-Nrg公司 | 神经调节素同种型，神经调节素多肽和其使用 |
| US20130217778A1 (en) * | 2010-07-21 | 2013-08-22 | Herman H. Vandenburgh | Methods and compositions for the improvement of skeletal muscle function in a mammal |
| CN102145164B (zh) * | 2010-12-16 | 2013-02-27 | 深圳市健元医药科技有限公司 | 一种更加稳定的iapp类似物注射剂 |
| UA113626C2 (xx) | 2011-06-02 | 2017-02-27 | Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії | |
| CA2841915A1 (en) * | 2011-07-28 | 2013-01-31 | Metanomics Gmbh | Means and methods for diagnosing and monitoring heart failure in a subject |
| CN115960249A (zh) | 2015-10-02 | 2023-04-14 | 银溪制药股份有限公司 | 用于组织修复的双特异性治疗性蛋白质 |
| AU2016375964A1 (en) * | 2015-12-22 | 2018-05-17 | Société des Produits Nestlé S.A. | Methods for treating sarcopenia and frailty |
| KR101908056B1 (ko) | 2017-05-25 | 2018-12-18 | 가천대학교 산학협력단 | 근아세포의 전기적 임피던스 모니터링 시스템 및 방법 |
| US20230145643A1 (en) * | 2020-03-31 | 2023-05-11 | Songhomitra Panda-Jonas | Agents for use in the therapeutic or prophylactic treatment of retinal pigment epithelium associated diseases |
| WO2024253228A1 (ko) * | 2023-06-09 | 2024-12-12 | 주식회사 메타파인즈 | 악액질 및 근손실의 예방 또는 치료용 조성물 |
| EP4582080A1 (en) | 2024-01-02 | 2025-07-09 | G.ST Antivirals GmbH | Dispenser for mucosal administration comprising 2-deoxy-glucose or analogues thereof |
| WO2025170936A1 (en) * | 2024-02-05 | 2025-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and methods for treating cardiac dysfunction |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2099304T3 (es) * | 1992-02-10 | 1997-05-16 | Takeda Chemical Industries Ltd | Mitogeno de la musculatura lisa y adn que lo codifica. |
| JP3945846B2 (ja) * | 1995-11-09 | 2007-07-18 | 武田薬品工業株式会社 | 膵臓機能改善剤 |
| CA2233009C (en) * | 1995-11-09 | 2005-05-10 | Takeda Chemical Industries, Ltd. | Composition for improving pancreatic function |
| DK1148129T3 (da) * | 1998-12-09 | 2007-10-15 | Takeda Pharmaceutical | Modifikation af betacellulin |
| ATE397959T1 (de) * | 1999-04-06 | 2008-07-15 | Genentech Inc | Verwendung von erbb-rezeptorliganden zur behandlung von diabetes |
| ATE364315T1 (de) * | 1999-04-26 | 2007-07-15 | Applied Protein Sciences Llc | Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung |
| US6815418B2 (en) * | 1999-08-19 | 2004-11-09 | Kaleidos Pharma, Inc. | TGF-α polypeptides, functional fragments and methods of use therefor |
| AUPQ496900A0 (en) * | 2000-01-06 | 2000-02-03 | Gropep Pty Ltd | Growth factor splice variant |
| IL153052A0 (en) * | 2000-05-23 | 2003-06-24 | Cenes Pharmaceuticals Inc | Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| US20040132679A1 (en) * | 2002-09-03 | 2004-07-08 | Baylor College Of Medicine | Induction of pancreatic islet formation |
| KR20050089156A (ko) * | 2002-12-04 | 2005-09-07 | 깃세이 야쿠힌 고교 가부시키가이샤 | 고혈당증에 기인하는 질환의 예방 또는 치료제 |
-
2006
- 2006-05-30 WO PCT/US2006/020797 patent/WO2006128125A2/en not_active Ceased
- 2006-05-30 JP JP2008513812A patent/JP2008545715A/ja active Pending
- 2006-05-30 US US11/442,244 patent/US20070054851A1/en not_active Abandoned
- 2006-05-30 CA CA002609728A patent/CA2609728A1/en not_active Abandoned
- 2006-05-30 EP EP06760525A patent/EP1890722A2/en not_active Withdrawn
- 2006-05-30 AU AU2006249327A patent/AU2006249327A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008545715A5 (https=) | ||
| JP2020033360A5 (https=) | ||
| HRP20131120T1 (hr) | Farmaceutski pripravak koji sadrži (1s)-1,5-anhidro-1-[5-(4-etoksibenzil)-2-metoksi-4-metilfenil]-1-tio-d-glucitol i metformin, te njegova uporaba za lijeäśenje dijabetesa | |
| JP2010530001A5 (https=) | ||
| JP2012520866A5 (https=) | ||
| JP2011500850A5 (https=) | ||
| JP2013541576A5 (https=) | ||
| NO20084919L (no) | Oksadiazolidindionforbindelse | |
| ES2334258T3 (es) | Control de la glucosa en sangre en el tratamiento de la diabetes que usa la insulina administrada pulmonarmente en combinacion con la insulina basal. | |
| JP2011241213A5 (https=) | ||
| JP2011529083A5 (https=) | ||
| JP2011512856A5 (https=) | ||
| MX2011007371A (es) | Metodo para tratar la hiperglucemia con la molecula. | |
| WO2007139941A3 (en) | Composition and methods for treatment of congestive heart failure | |
| JP2019517542A5 (https=) | ||
| MX336657B (es) | Prevencion de hipoglucemia en pacientes con diabetes sacarina de tipo 2. | |
| ME01546B (me) | Liksisenatid kao dodatna terapija insulin glarginu i metforminu za liječenje dijabetesa tipa 2 | |
| JP2018509419A5 (https=) | ||
| JP2013541583A5 (https=) | ||
| JP2021529829A5 (https=) | ||
| JP2008545703A5 (https=) | ||
| JP2020536121A5 (https=) | ||
| JP2007119497A5 (https=) | ||
| JP2011500589A5 (https=) | ||
| WO2009133470A3 (en) | Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level |